封面
市场调查报告书
商品编码
1955105

生物净化市场:市场规模、份额、成长率、产业分析、按类型、应用和地区分類的分析以及未来预测(2026-2034 年)

Bio-Decontamination Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 143 Pages | 商品交期: 请询问到货日

价格

生物净化市场成长要素

随着各行各业和医疗机构日益重视消除有害微生物以预防感染和污染,全球生物净化市场正稳定成长。根据 Fortune Business Insights 预测,该市场规模预计将在 2025 年达到 2.199 亿美元,并在 2026 年增长至 2.286 亿美元。到 2034 年,市场规模预计将达到 3.293 亿美元,在 2026 年至 2034 年的预测期内,复合年增长率 (CAGR) 为 4.70%。

市场概况及成长要素

生物净化是医疗机构、製药生产和医疗设备製造中的关键製程。它采用物理和化学方法去除有害微生物,确保无菌环境。生物净化解决方案的日益普及主要受住院率、外科手术量以及医院感染(HAI)流行率上升的推动。预计到2025年,北美将以34.60%的市场份额引领市场,这主要得益于严格的感染控制法规以及对医疗净化工艺投入的增加。

製药和医疗设备製造商、研究机构和医院正在大力投资生物净化系统,以确保最终产品的无菌性。在严格的法规结构下,新药和医疗设备的上市受到越来越多的关注,这进一步推动了这项需求。例如,美国FDA在2023年核准了53种新药,高于2022年的37种,这迫使製造商实施先进的净化程序以满足安全标准。

新冠疫情对市场的影响

新冠疫情加速了生物消毒产品的普及应用。医疗和製药业对灭菌和消毒需求的激增凸显了高效消毒解决方案的重要性。例如,TOMI Environmental Solutions, Inc.等公司2020年的营收较2019年成长了249.3%,反映了市场需求的激增。疫情过后,随着产品使用恢復正常,市场成长趋于稳定,TOMI在2022年实现了7.5%的年成长。

市场趋势和技术整合

市场参与者正在加速整合先进技术以提高效率。例如,2023年9月,Telstar推出了一款配备离子化过氧化氢(ionHP+)系统的安全气锁系统(SAS)。该系统能够将生物污染负荷降低六个数量级(log 6),同时最大限度地减少材料劣化。此类技术创新满足了无菌製药生产和研究环境的需求,并持续推动市场成长。

细分市场分析

  • 产品细分:受监管要求、技术进步以及对自动化消毒系统日益增长的需求的推动,设备将主导市场,到 2026 年将占 80.23%(1.834 亿美元)的份额。随着医疗和製药行业应用范围的扩大,耗材预计将稳定成长。
  • 按类型划分:受製药生产和研发中物料转移需求的推动,预计到 2026 年,舱室消毒将占市场份额的 55.03%(1.258 亿美元)。舱室消毒方法的应用正在不断扩大,以减少医院获得性感染和手术部位感染。
  • 按消毒剂种类划分:过氧化氢因其安全性和有效性而成为领先的消毒剂,预计到 2026 年将占市场份额的 62.82%(1.436 亿美元)。二氧化氯是第二大消毒剂,这得益于其在灭菌应用方面获得的监管核准不断增加。
  • 按最终用户划分:在严格的产品安全准则的支持下,製药和医疗设备製造商预计将在 2026 年占据 63.47% 的市场份额(1.451 亿美元)。医院、医疗机构和研究机构也是重要的采用者,这主要得益于外科手术量的增加和感染预防需求的成长。

区域洞察

截至2025年,北美将以7,602万美元的市场规模引领市场,主要驱动因素为高住院率、外科手术以及消毒技术的应用。欧洲紧追在后,预计到2026年,英国和德国的市场规模将分别达到1,140万美元和1,500万美元。亚太地区预计将达到最高的复合年增长率,预计到2026年,中国将达到1,450万美元,日本将达到1,880万美元,印度将达到770万美元。这主要得益于製药业的扩张和感染控制意识的提高。

主要企业及策略趋势

市场呈现半集中式格局,主要参与者包括STERIS(美国)、Bioquell(英国)、TOMI Environmental Solutions, Inc.(美国)和Amira Srl Unipersonale(义大利)。每家公司都专注于策略联盟、产品推出以及併购,以拓展业务。关键进展包括STERIS于2021年推出新一代过氧化氢蒸气系统,以及TOMI于2023年与Cellares合作,将iHP技术整合到细胞疗法生产流程中。

目录

第一章:引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章 主要考虑因素

  • 生物净化产品的技术进步
  • 产业重大发展:合併、联盟与收购。
  • 新产品发布
  • 新冠疫情对生物净化市场的影响

第五章:全球生物净化市场分析:洞察与预测(2021-2034)

  • 市场分析、洞察与预测:按产品分类
    • 装置
    • 消耗品
  • 市场分析、洞察与预测:按药物类型划分
    • 过氧化氢
    • 二氧化氯
    • 过氧乙酸
    • 二氧化氮
  • 市场分析、洞察与预测:按类型
    • 舱室消毒
    • 室内消毒
  • 市场分析、洞察与预测:按最终用户划分
    • 製药和医疗设备製造商
    • 製药契约製造和开发组织
    • 医院和医疗设施
    • 其他的
  • 市场分析、洞察与预测:按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 其他地区(ROW)

第六章:北美生物净化市场分析:洞察与预测(2021-2034)

  • 国家
    • 我们
    • 加拿大

第七章:欧洲生物净化市场分析:洞察与预测(2021-2034)

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章:亚太生物净化市场分析:洞察与预测(2021-2034)

  • 国家
    • 日本
    • 中国
    • 印度
    • 亚太其他地区

第九章:其他地区(ROW)生物净化市场分析:探讨与预测(2021-2034 年)

第十章 竞争分析

  • 全球市占率分析(2025 年)
  • 公司简介
    • STERIS
    • Bioquell(Ecolab)
    • JCE Biotechnology
    • Fedegari Autoclavi SpA
    • TOMI Environmental Solutions, Inc.
    • Amira Srl Unipersonale
    • Zhejiang Tailin Bioengineering Co., Ltd.
    • Noxilizer, Inc.
    • ChlorDisys Solutions Inc.
Product Code: FBI107160

Growth Factors of bio-decontamination Market

The global bio-decontamination market is witnessing steady growth as industries and healthcare facilities focus on eliminating harmful microorganisms to prevent infection and contamination. According to Fortune Business Insights, the market was valued at USD 219.9 million in 2025 and is projected to grow to USD 228.6 million in 2026. By 2034, the market is expected to reach USD 329.3 million, registering a CAGR of 4.70% during the forecast period from 2026 to 2034.

Market Overview and Growth Drivers

Bio-decontamination is a critical process in healthcare facilities, pharmaceutical production, and medical device manufacturing. It involves the use of physical and chemical methods to eliminate harmful microorganisms and ensure sterile conditions. The rising adoption of bio-decontamination solutions is largely fueled by the increasing number of hospital admissions, surgical procedures, and the prevalence of hospital-acquired infections (HAIs). North America dominated the market in 2025 with a 34.60% share, driven by stringent infection control regulations and growing investments in healthcare decontamination processes.

Pharmaceutical and medical device manufacturers, research organizations, and hospitals are investing significantly in bio-decontamination systems to ensure sterile end products. The growing focus on launching new drugs and medical devices under strict regulatory frameworks has further increased demand. For instance, the U.S. FDA approved 53 novel drugs in 2023, compared to 37 in 2022, compelling manufacturers to implement advanced decontamination procedures to meet safety standards.

COVID-19 Impact on the Market

The COVID-19 pandemic accelerated the adoption of bio-decontamination products. Increased demand for sterilization and disinfection in healthcare and pharmaceutical settings highlighted the importance of effective decontamination solutions. Companies such as TOMI Environmental Solutions, Inc. witnessed revenue growth of 249.3% in 2020 compared to 2019, reflecting the surge in demand. Post-pandemic, market growth stabilized, with TOMI reporting 7.5% growth in 2022 compared to 2021, as product utilization normalized.

Market Trends and Technological Integration

Market players are increasingly integrating advanced technologies to enhance efficiency. For example, Telstar introduced the Safety Airlock System (SAS) with its ionized Hydrogen Peroxide (ionHP+) system in September 2023, allowing a log 6 reduction in bioburden while minimizing material degradation. Such technological innovations continue to propel market growth, catering to aseptic pharmaceutical manufacturing and research environments.

Segment Analysis

  • By Product: Equipment dominates the market, accounting for 80.23% in 2026 with a value of USD 183.4 million, due to regulatory requirements, technological advancements, and the growing need for automated decontamination systems. Consumables are expected to grow steadily with increasing availability and adoption in healthcare and pharmaceutical sectors.
  • By Type: Chamber decontamination held a 55.03% share in 2026 (USD 125.8 million), driven by material transfer needs in drug manufacturing and research. Room decontamination methods are gaining traction to reduce hospital-acquired and surgical site infections.
  • By Agent: Hydrogen peroxide is the leading decontamination agent, representing 62.82% in 2026 (USD 143.6 million) due to its safety and effectiveness. Chlorine dioxide is the second-largest segment, benefiting from increasing regulatory approvals for sterilization use.
  • By End-user: Pharmaceutical & medical device manufacturers accounted for 63.47% of the market in 2026 (USD 145.1 million), supported by stringent guidelines for product safety. Hospitals, healthcare facilities, and research organizations are also significant adopters, driven by rising surgical procedures and infection prevention needs.

Regional Insights

North America led the market in 2025 with a value of USD 76.02 million, driven by high hospital admissions, surgical procedures, and adoption of decontamination practices. Europe follows, with the UK and Germany markets projected at USD 11.4 million and USD 15 million by 2026, respectively. Asia Pacific is expected to register the highest CAGR, with China at USD 14.5 million, Japan at USD 18.8 million, and India at USD 7.7 million by 2026, due to growing pharmaceutical manufacturing and infection control awareness.

Key Players and Strategic Developments

The market is semi-consolidated, with major players including STERIS (U.S.), Bioquell (U.K.), TOMI Environmental Solutions, Inc. (U.S.), and Amira Srl Unipersonale (Italy). Companies are focusing on strategic collaborations, product launches, and mergers & acquisitions to expand their footprint. Notable developments include STERIS launching next-generation vaporized hydrogen peroxide systems in 2021 and TOMI partnering with Cellares in 2023 to integrate iHP technology into cell therapy manufacturing.

Conclusion

The bio-decontamination market is poised for significant growth between 2025 and 2034, driven by increasing healthcare demands, regulatory pressures, and technological advancements. While product recalls and certain operational limitations may restrain growth, the rising focus on infection control, aseptic manufacturing, and research safety will continue to drive adoption across pharmaceutical, medical device, and healthcare sectors. North America will maintain its leadership, while Asia Pacific offers high-growth opportunities due to expanding manufacturing and heightened awareness regarding contamination prevention.

Segmentation By Product

  • Equipment
  • Consumables

By Type

  • Chamber Decontamination
  • Room Decontamination

By Agent

  • Hydrogen Peroxide
  • Chlorine Dioxide
  • Peracetic Acid
  • Nitrogen Dioxide

By End User

  • Pharmaceutical & Medical Device Manufacturers
  • Contract Manufacturing and Research Organizations
  • Hospital & Healthcare Facilities
  • Others

By Region

  • North America (By Product, Type, Agent, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Type, Agent, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Product, Type, Agent, End-user, and Country/Sub-region)
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Rest of World (By Product, Type, Agent, and End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Bio-Decontamination Products
  • 4.2. Key Industry Developments: Mergers, Partnership, Acquisitions
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on Bio-Decontamination Market

5. Global Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Equipment
    • 5.1.2. Consumables
  • 5.2. Market Analysis, Insights and Forecast - By Agent
    • 5.2.1. Hydrogen Peroxide
    • 5.2.2. Chlorine Dioxide
    • 5.2.3. Peracetic Acid
    • 5.2.4. Nitrogen Dioxide
  • 5.3. Market Analysis, Insights and Forecast - By Type
    • 5.3.1. Chamber Decontamination
    • 5.3.2. Room Decontamination
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Pharmaceutical & Medical Device Manufacturers
    • 5.4.2. Contract Manufacturing and Research Organizations
    • 5.4.3. Hospitals & Healthcare Facilities
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World

6. North America Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Equipment
    • 6.1.2. Consumables
  • 6.2. Market Analysis, Insights and Forecast - By Agent
    • 6.2.1. Hydrogen Peroxide
    • 6.2.2. Chlorine Dioxide
    • 6.2.3. Peracetic Acid
    • 6.2.4. Nitrogen Dioxide
  • 6.3. Market Analysis, Insights and Forecast - By Type
    • 6.3.1. Chamber Decontamination
    • 6.3.2. Room Decontamination
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Pharmaceutical & Medical Device Manufacturers
    • 6.4.2. Contract Manufacturing and Research Organizations
    • 6.4.3. Hospitals & Healthcare Facilities
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Equipment
    • 7.1.2. Consumables
  • 7.2. Market Analysis, Insights and Forecast - By Agent
    • 7.2.1. Hydrogen Peroxide
    • 7.2.2. Chlorine Dioxide
    • 7.2.3. Peracetic Acid
    • 7.2.4. Nitrogen Dioxide
  • 7.3. Market Analysis, Insights and Forecast - By Type
    • 7.3.1. Chamber Decontamination
    • 7.3.2. Room Decontamination
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Pharmaceutical & Medical Device Manufacturers
    • 7.4.2. Contract Manufacturing and Research Organizations
    • 7.4.3. Hospitals & Healthcare Facilities
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Rest of Europe

8. Asia Pacific Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Equipment
    • 8.1.2. Consumables
  • 8.2. Market Analysis, Insights and Forecast - By Agent
    • 8.2.1. Hydrogen Peroxide
    • 8.2.2. Chlorine Dioxide
    • 8.2.3. Peracetic Acid
    • 8.2.4. Nitrogen Dioxide
  • 8.3. Market Analysis, Insights and Forecast - By Type
    • 8.3.1. Chamber Decontamination
    • 8.3.2. Room Decontamination
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Pharmaceutical & Medical Device Manufacturers
    • 8.4.2. Contract Manufacturing and Research Organizations
    • 8.4.3. Hospitals & Healthcare Facilities
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Rest of Asia Pacific

9. Rest of the World Bio-Decontamination Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Equipment
    • 9.1.2. Consumables
  • 9.2. Market Analysis, Insights and Forecast - By Agent
    • 9.2.1. Hydrogen Peroxide
    • 9.2.2. Chlorine Dioxide
    • 9.2.3. Peracetic Acid
    • 9.2.4. Nitrogen Dioxide
  • 9.3. Market Analysis, Insights and Forecast - By Type
    • 9.3.1. Chamber Decontamination
    • 9.3.2. Room Decontamination
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Pharmaceutical & Medical Device Manufacturers
    • 9.4.2. Contract Manufacturing and Research Organizations
    • 9.4.3. Hospitals & Healthcare Facilities
    • 9.4.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. STERIS
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. Bioquell (Ecolab)
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. JCE Biotechnology
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Fedegari Autoclavi S.p.A.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. TOMI Environmental Solutions, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Amira Srl Unipersonale
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Zhejiang Tailin Bioengineering Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Noxilizer, Inc.
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. ChlorDisys Solutions Inc.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products
      • 10.2.9.3. SWOT analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 02: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 03: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 04: Global Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 05: Global Bio-Decontamination Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 06: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 07: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 08: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 09: North America Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 10: North America Bio-Decontamination Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 11: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 12: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 13: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 14: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 15: Europe Bio-Decontamination Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 17: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 18: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 19: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Bio-Decontamination Market Revenue (USD million) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Product, 2021-2034
  • Table 22: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Agent, 2021-2034
  • Table 23: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 24: Rest of the World Bio-Decontamination Market Revenue (USD million) Forecast, By End User, 2021-2034

List of Figures

  • Figure 01: Global Bio-Decontamination Market Value Share (%), By Product, 2025 & 2034
  • Figure 02: Global Bio-Decontamination Market Value Share (%), By Agent, 2025 & 2034
  • Figure 03: Global Bio-Decontamination Market Value Share (%), By Type, 2025 & 2034
  • Figure 04: Global Bio-Decontamination Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Bio-Decontamination Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 07: North America Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 08: North America Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 09: North America Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 10: North America Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 11: North America Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 12: North America Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 13: North America Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 14: North America Bio-Decontamination Market Value (USD million), By Country, 2025 & 2034
  • Figure 15: North America Bio-Decontamination Market Value Share (%), By Country, 2025
  • Figure 16: Europe Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 17: Europe Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 18: Europe Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 19: Europe Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 20: Europe Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 21: Europe Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 22: Europe Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 23: Europe Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 24: Europe Bio-Decontamination Market Value (USD million), By Country/Sub-Region, 2025 & 2034
  • Figure 25: Europe Bio-Decontamination Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 26: Asia Pacific Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 27: Asia Pacific Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 28: Asia Pacific Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 29: Asia Pacific Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 30: Asia Pacific Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 31: Asia Pacific Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 32: Asia Pacific Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 33: Asia Pacific Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 34: Asia Pacific Bio-Decontamination Market Value (USD million), By Country/ Sub-Region, 2025 & 2034
  • Figure 35: Asia Pacific Bio-Decontamination Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 36: Rest of the World Bio-Decontamination Market Value (USD million), By Product, 2025 & 2034
  • Figure 37: Rest of the World Bio-Decontamination Market Value Share (%), By Product, 2025
  • Figure 38: Rest of the World Bio-Decontamination Market Value (USD million), By Agent, 2025 & 2034
  • Figure 39: Rest of the World Bio-Decontamination Market Value Share (%), By Agent, 2025
  • Figure 40: Rest of the World Bio-Decontamination Market Value (USD million), By Type, 2025 & 2034
  • Figure 41: Rest of the World Bio-Decontamination Market Value Share (%), By Type, 2025
  • Figure 42: Rest of the World Bio-Decontamination Market Value (USD million), By End User, 2025 & 2034
  • Figure 43: Rest of the World Bio-Decontamination Market Value Share (%), By End User, 2025
  • Figure 44: Global Bio-Decontamination Market Share (%), 2025